Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My‐LIFE European Delphi survey

• Published in: European journal of pain Vol. 25; no. 10; pp. 2177 - 2189
• Main Authors: Pozo‐Rosich, Patricia, Gil‐Gouveia, Raquel, Donnet, Anne, Poole, Anne‐Christine, Gendolla, Astrid, Afridi, Shazia, Sanchez‐De la Rosa, Rainel, Terwindt, Gisela M., Tassorelli, Cristina
• Format: Journal Article
• Language: English
• Published: 01.11.2021

Background Clinical guidelines agree that preventive treatment should be considered in patients with uncontrolled migraine despite acute medications or patients with ≥4 migraine days per month. However, the criteria to define the effectiveness of treatment and the factors that inform the decision to...